4
Changes in Ownership
HAEMONETICS CORP Filed Acc 0001127602-19-027768
EVP, Chief Technology Officer sold 657 shares at $133.73 ($87,861)
- EVP, Chief Technology Officer acquired 832 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bolorforosh Said EVP, Chief Technology Officer | 2019-08-30 | Option exercise | +832 | $93.52 | $77,809 | 2,973 | D |
| Bolorforosh Said EVP, Chief Technology Officer | 2019-08-30 | Sale | −657 | $133.73 | $87,861 | 2,316 | D |
| Derivatives | |||||||
| Bolorforosh Said EVP, Chief Technology Officer | 2019-08-30 | Option exercise · Non-qualified Stock Option (Right to Buy) | −832 | 2,498 | D | ||
| Open-market sales · 657 sh · avg $133.73 · $87,861 | |||||||
Loading xslF345X03/form4.xml…